PRICE MICHAEL DENNIS (Chief Financial Officer) received a stock award from AKCEA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2020ACC: 0001209191-20-030621
Officer· Chief Financial Officer
Since May 2020
+350K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
350K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
New position
5/18/2020
0.00→50K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2020 | A · Award | +50K | — | — | New position | 0.00 | 50K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
300K shares
Shares
+300K
Strike price
14.78
Held after
300K
Exercisable
—
5/18/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock300K shares | 5/18/2020 | A · Award | +300K | 14.78 | — | 300K |